KIR3DL1 and neoplasm: We have initially assessed the entire set of KIR genes by PCR and, by determining the genotype, we could further divide our subjects into the AA haplotypes including predominantly inhibitory KIRs and Bx haplotypes, which include mostly activating KIRs and are considered more advantageous for anti-tumor responses.